Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC
Clinical trial NCT06123754 · RECRUITING
Trial details
- NCT number
- NCT06123754
- Sponsor
- 3D Medicines (Sichuan) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2027-12-30
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.